Shaobao Wang
5Patents
0h-index
14Co-inventors
34Inventor score
Filing activity: Aug 19, 2014 → Dec 3, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11667631B2 | FGFR4 inhibitor, preparation method therefor, and applications thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US10011627B2 | C-aryl glucoside derivative, preparation methods thereof, and medical applications thereof | Chemistry; Metallurgy | 0 | Active |
| US10259820B2 | EGFR inhibitor, preparation method and use thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US10428081B2 | EGFR inhibitor, preparation method and use thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US11136324B2 | Substituted imidazoles as apoptosis signal regulating kinase 1 inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.